These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6736500)

  • 21. Free and conjugated 3-methoxy-4-hydroxyphenylglycol in human urine: peripheral origin of glucuronide.
    Peyrin L; Pequignot JM
    Psychopharmacology (Berl); 1983; 79(1):16-20. PubMed ID: 6403958
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The determination of urinary 3-methoxy-4-hydroxyphenylglycol excretion in acute schizophreniform and depressed patients.
    DeLisi LE; Karoum F; Targum S; Byrnes S; Wyatt RJ
    Biol Psychiatry; 1983 Oct; 18(10):1189-96. PubMed ID: 6652159
    [No Abstract]   [Full Text] [Related]  

  • 23. High correlation of norepinephrine and its major metabolite excretion rates.
    Linnoila M; Karoum F; Potter WZ
    Arch Gen Psychiatry; 1982 May; 39(5):521-3. PubMed ID: 7092485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decrease of urinary levels of adrenergic metabolites including conjugated MHPG after a short term course of diethylpropion in obese children fed a mixed, low-calorie diet.
    Popa M; Stefănescu AM; Dumitriu L
    Endocrinologie; 1987; 25(3):179-86. PubMed ID: 3685848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of diet on urinary MHPG excretion in depressed patients and normal control subjects.
    Muscettola G; Wehr T; Goodwin FK
    Am J Psychiatry; 1977 Aug; 134(8):914-6. PubMed ID: 879357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Excretion of metabolites of biogenic amines in patients with irradiated brain tumours.
    Pericić D; Deanović Z; Pavicić S
    Acta Radiol Ther Phys Biol; 1976 Feb; 15(1):81-90. PubMed ID: 775892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urinary 3-methoxy-4-hydroxyphenylglycol sulfate excretion in seventy-three schoolchildren with minimal brain dysfunction syndrome.
    Shen YC; Wang YF
    Biol Psychiatry; 1984 Jun; 19(6):861-70. PubMed ID: 6743722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary excretion of catecholamines and metabolites in the Lyon strain of genetic hypertensive rats.
    Peyrin L; Cottet-Emard JM; Renaud B; Vincent M; Sassard J
    Clin Exp Hypertens (1978); 1980 Feb; 2(2):297-307. PubMed ID: 7418544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urinary excretion of catechol metabolites particularly MHPG in children. Relation to age, body mass indices and thyroid function.
    Popa M; Stefănescu AM; Dumitriu L
    Endocrinologie; 1986; 24(3):203-14. PubMed ID: 3775226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduction in human urinary MHPG excretion by guanethidine: urinary MHPG as index of sympathetic nervous activity.
    Izzo JL; Horwitz D; Keiser HR
    Life Sci; 1979 Apr; 24(15):1403-6. PubMed ID: 481089
    [No Abstract]   [Full Text] [Related]  

  • 31. A fluorometric technique for measuring urinary 3-methoxy-4-hydroxyphenylethylene glycol.
    Zawad JS; Brown FC
    Clin Chim Acta; 1976 Nov; 73(1):187-9. PubMed ID: 1000829
    [No Abstract]   [Full Text] [Related]  

  • 32. Toward a biochemical classification of depressive disorders. I. Differences in urinary excretion of MHPG and other catecholamine metabolites in clinically defined subtypes of depressions.
    Schildkraut JJ; Orsulak PJ; Schatzberg AF; Gudeman JE; Cole JO; Rohde WA; LaBrie RA
    Arch Gen Psychiatry; 1978 Dec; 35(12):1427-33. PubMed ID: 727878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urine excretion of methoxy-hydroxyphenylglycol: a method of measure.
    Reynders J; Toscano-Aguilar M; Libotte M
    Acta Psychiatr Belg; 1984; 84(3):249-51. PubMed ID: 6485842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urinary 3-methoxy-4-hydroxyphenylglycol determination using reversed-phase chromatography with amperometric detection.
    Santagostino G; Frattini P; Schinelli S; Cucchi ML; Corona GL
    J Chromatogr; 1982 Dec; 233():89-95. PubMed ID: 7161365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urinary amine metabolite excretion in a patient with adrenergic hyperactivity state: reaction to phenelzine withdrawal and combined treatment.
    Modai I; Beigel Y; Cygielman G
    J Clin Psychiatry; 1986 Feb; 47(2):92-3. PubMed ID: 2418010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Norepinephrine metabolites as biochemical criteria for classifying depressive disorders and predicting responses to treatment: preliminary findings.
    Schildkraut JJ
    Am J Psychiatry; 1973 Jun; 130(6):695-9. PubMed ID: 4701961
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of renal failure on plasma dihydroxyphenylglycol, 3-methoxy-4-hydroxyphenylglycol, and vanillymandelic acid.
    Hoeldtke RD; Israel BC; Cavanaugh ST; Krishna GG
    Clin Chim Acta; 1989 Sep; 184(2):195-6. PubMed ID: 2605785
    [No Abstract]   [Full Text] [Related]  

  • 38. Thin layer chromatographic screening test for urinary 3-methoxy-4-hydroxyphenylethylene glycol; results from cases of secreting neuroblastoma.
    Ebinger G; Verheyden R
    Z Klin Chem Klin Biochem; 1975 May; 13(5):213-4. PubMed ID: 1210505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reliability of urinary monoamine and metabolite output measurements in depressed patients.
    Linnoila M; Karoum F; Miller T; Potter WZ
    Am J Psychiatry; 1983 Aug; 140(8):1055-7. PubMed ID: 6191580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urinary excretion of catecholamine metabolites in hyperkinetic child syndrome.
    Khan AU; Dekirmenjian H
    Am J Psychiatry; 1981 Jan; 138(1):108-10. PubMed ID: 7446760
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.